A detailed history of Capital Analysts, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Capital Analysts, LLC holds 109,769 shares of MDT stock, worth $8.52 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
109,769
Previous 89,394 22.79%
Holding current value
$8.52 Million
Previous $7.36 Million 29.92%
% of portfolio
0.45%
Previous 0.37%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$82.84 - $88.09 $1.69 Million - $1.79 Million
20,375 Added 22.79%
109,769 $9.57 Million
Q4 2023

Jan 30, 2024

BUY
$69.43 - $83.43 $92,827 - $111,545
1,337 Added 1.52%
89,394 $7.36 Million
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $711,176 - $821,916
9,092 Added 11.51%
88,057 $6.9 Million
Q2 2023

Aug 11, 2023

BUY
$79.47 - $91.38 $531,177 - $610,783
6,684 Added 9.25%
78,965 $6.96 Million
Q1 2023

May 05, 2023

BUY
$76.72 - $87.58 $731,601 - $835,162
9,536 Added 15.2%
72,281 $5.83 Million
Q4 2022

Feb 08, 2023

BUY
$76.18 - $87.74 $155,788 - $179,428
2,045 Added 3.37%
62,745 $4.88 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $437,745 - $516,675
5,421 Added 9.81%
60,700 $4.9 Million
Q2 2022

Aug 12, 2022

BUY
$87.4 - $113.09 $278,718 - $360,644
3,189 Added 6.12%
55,279 $4.96 Million
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $295,302 - $329,947
2,936 Added 5.97%
52,090 $5.78 Million
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $351,539 - $451,213
3,532 Added 7.74%
49,154 $5.09 Million
Q3 2021

Nov 04, 2021

BUY
$122.75 - $135.17 $158,224 - $174,234
1,289 Added 2.91%
45,622 $5.72 Million
Q2 2021

Nov 15, 2021

SELL
$118.19 - $131.5 $71,268 - $79,294
-603 Reduced 1.34%
44,333 $5.5 Million
Q2 2021

Aug 05, 2021

BUY
$118.19 - $131.5 $113,462 - $126,240
960 Added 2.18%
44,936 $5.58 Million
Q1 2021

May 17, 2021

BUY
$111.18 - $119.74 $211,464 - $227,745
1,902 Added 4.52%
43,976 $5.2 Million
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $118,471 - $137,990
1,178 Added 2.88%
42,074 $4.93 Million
Q3 2020

Nov 12, 2020

SELL
$90.13 - $108.78 $17,304 - $20,885
-192 Reduced 0.47%
40,896 $4.25 Million
Q2 2020

Aug 07, 2020

SELL
$84.11 - $103.33 $129,361 - $158,921
-1,538 Reduced 3.61%
41,088 $3.77 Million
Q1 2020

May 08, 2020

BUY
$72.92 - $121.3 $33,834 - $56,283
464 Added 1.1%
42,626 $3.84 Million
Q4 2019

Feb 12, 2020

SELL
$104.49 - $114.54 $40,960 - $44,899
-392 Reduced 0.92%
42,162 $4.78 Million
Q3 2019

Nov 12, 2019

BUY
$98.02 - $111.18 $8,331 - $9,450
85 Added 0.2%
42,554 $4.62 Million
Q2 2019

Aug 13, 2019

SELL
$84.15 - $99.38 $138,342 - $163,380
-1,644 Reduced 3.73%
42,469 $4.14 Million
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $3.61 Million - $4.11 Million
43,843 Added 16238.15%
44,113 $4.02 Million
Q4 2018

Feb 13, 2019

SELL
$85.8 - $99.49 $23,852 - $27,658
-278 Reduced 50.73%
270 $25,000
Q3 2018

Nov 07, 2018

BUY
$85.91 - $99.17 $85 - $99
1 Added 0.18%
548 $0
Q2 2018

Aug 03, 2018

BUY
$77.48 - $87.83 $154 - $175
2 Added 0.37%
547 $0
Q1 2018

May 14, 2018

BUY
$76.55 - $87.26 $76 - $87
1 Added 0.18%
545 $44,000
Q4 2017

Feb 12, 2018

BUY
$76.93 - $83.5 $76 - $83
1 Added 0.18%
544 $44,000
Q3 2017

Nov 06, 2017

BUY
$77.71 - $84.6 $42,196 - $45,937
543
543 $42,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.